Bojangles’, Inc. Reports Financial Results for its First Fiscal Quarter 2017
May 02, 2017 20:07 pm UTC| Business
CHARLOTTE, N.C., May 02, 2017 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week first fiscal quarter ended March 26, 2017. Bojangles’ also reiterated its annual guidance...
Bojangles’, Inc. Reports Financial Results for its First Fiscal Quarter 2017
May 02, 2017 20:07 pm UTC| Business
CHARLOTTE, N.C., May 02, 2017 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week first fiscal quarter ended March 26, 2017. Bojangles’ also reiterated its annual guidance...
Bojangles’, Inc. Reports Financial Results for its First Fiscal Quarter 2017
May 02, 2017 20:07 pm UTC| Business
CHARLOTTE, N.C., May 02, 2017 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week first fiscal quarter ended March 26, 2017. Bojangles’ also reiterated its annual guidance...
Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting
May 02, 2017 20:06 pm UTC| Business
RANCHO CORDOVA, Calif., May 02, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that ThermoGenesis, the...
Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting
May 02, 2017 20:06 pm UTC| Business
RANCHO CORDOVA, Calif., May 02, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that ThermoGenesis, the...
Aduro Biotech Reports First Quarter 2017 Financial Results
May 02, 2017 20:06 pm UTC| Business
BERKELEY, Calif., May 02, 2017 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the first quarter ended March 31, 2017. Net loss for the first quarter of 2017 was $21.8 million, or $0.32 per...
Aduro Biotech Reports First Quarter 2017 Financial Results
May 02, 2017 20:06 pm UTC| Business
BERKELEY, Calif., May 02, 2017 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the first quarter ended March 31, 2017. Net loss for the first quarter of 2017 was $21.8 million, or $0.32 per...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India